CD8 Minibody Repeatability Study
Clinical trial NCT05744128 · TERMINATED
Trial details
- NCT number
- NCT05744128
- Sponsor
- ImaginAb, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-16
- Primary completion
- 2024-05-31
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.